{"id":7492,"date":"2025-08-08T11:16:36","date_gmt":"2025-08-08T09:16:36","guid":{"rendered":"https:\/\/beigen.vipdev.lndo.site\/us\/?post_type=clinical-trial&#038;p=7492"},"modified":"2025-08-08T11:16:36","modified_gmt":"2025-08-08T09:16:36","slug":"rationale-306-trial","status":"publish","type":"clinical-trial","link":"https:\/\/beonemedaffairs.com\/us\/clinical-trial\/7492\/rationale-306-trial\/","title":{"rendered":"RATIONALE-306 Trial"},"content":{"rendered":"","protected":false},"template":"","post-tag":[],"class_list":["post-7492","clinical-trial","type-clinical-trial","status-publish","hentry","content_type-reading","disease_state-esophageal-squamous-cell-carcinoma","molecule-tislelizumab"],"acf":{"summary":"RATIONALE-306 (NCT03783442) is a global, Phase 3, randomized, double-blind, placebo-controlled trial assessing tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment in patients with advanced or metastatic esophageal squamous cell carcinoma (ESCC).","study_status":"complete","cancer_type":false,"authors":"","related_posts":[{"id":7473,"title":"RATIONALE-306 Trial","title_guest":"","summary":"RATIONALE-306 (NCT03783442) is a global, Phase 3, randomized, double-blind, placebo-controlled trial assessing tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment in patients with advanced or metastatic esophageal squamous cell carcinoma (ESCC).","summary_guest":"","content-type":4,"post_image":7474,"blur_thumbnail_guest":false,"post_image_guest":false,"videolange":null,"url":"https:\/\/beonemedaffairs.com\/us\/7473\/rationale-306-trial\/","date":"2025-08-08T10:59:42","date_gmt":"2025-08-08T08:59:42"}],"content-type":246,"download_file_reading":null,"display_file_reading":null,"download_file_slidekit":null,"display_file_slidekit":null,"3qsdn":"","webcast":"","videolange":null,"fliphtml_link":""},"_links":{"self":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/clinical-trial\/7492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/clinical-trial"}],"about":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/types\/clinical-trial"}],"acf:term":[{"embeddable":true,"taxonomy":"content_type","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/content_type\/246"}],"acf:post":[{"embeddable":true,"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/posts\/7473"}],"wp:attachment":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/media?parent=7492"}],"wp:term":[{"taxonomy":"post-tag","embeddable":true,"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag?post=7492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}